Methaemoglobinemia is a potentially fatal and rare condition. The most common cause of methaemoglobinemia is the ingestion or inhalation of oxidizing agents such as nitrates and nitrites. 1 Nitrobenzene is a poisonous agent not commonly encountered in clinical practice, which belongs to the group of aniline dyes & causes methaemoglobinemia. It is also known as nitrobenzol or oil of mirbane, is a pale yellow oily liquid with a characteristic odour like bitter almond. Two rare cases of nitrobenzene ingestion came to our emergency department, with ingestion of nitrobenzene dye on two different days. They were treated with ventilatory support and exchange transfusion, but we could save only one life.
Case Report Case no-1:
A 20 year old girl was admitted to our hospital emergency department in the evening, with a history of ingestion of about 100ml of a dye used in printing 12 hours ago. On examination she was cyanosed, her GCS (Glasgow coma scale) was 3 (E 1 3 The absorption spectra showed wavelength peak of 258 nm matching with the pure nitrobenzene. Immediate gastric lavage was carried out. 100% O 2 was given through the ventilator. Due to non availability of intravenous methylene blue, we could not give her the specific antidote. Symptomatic treatment and vitamin C was started. Exchange transfusion was done twice with two units of packed red cells. Inspite of treatment her condition deteriorated. 8 hrs after admission to the ICU she developed a cardiac arrest, from which she could not be revived.
Case no-2
A 26yr old young man, a worker in the dye industry came to our emergency department with similar complaints like in the above mentioned patient. His GCS was 3 (E 1 V 1 M 1) at the time of presentation. He was intubated and was ventilated on SIMV mode.
On examination peripheral and central cyanosis was observed, pulse was 94/min and blood pressure 124/74 mm Hg. On pulse oximetry SpO 2 was 80%. The blood gas analysis showed pH -7.36, PaO 2 -248.7 mmHg, PaCO 2 -31.2mmHg, HCO3-24.4 meq/l. Serum electrolytes were within normal limits. Haemoglobin was 13.2 gm/dl, WBC count was 9,400/dl. Blood urea, serum creatinine, liver function tests were within normal limits. Blood drawn for investigation was chocolate brown in colour. A filter paper test had confirmed nitrobenzene poisoning. Treatment was similar to the previous patient, in addition he was given Methylene blue through Ryle's tube and repeated after two hours (The recommended route is intravenous only for methylene blue but due to non-availability of IV preparation we had to give it via Ryle's tube). Patient's condition improved due to methylene blue and SpO 2 increased gradually. Patient was extubated after two days and after receiving treatment in the ICU for one more day, the patient was discharged.
Discussion
Nitrobenzene is used as a solvent, for the manufacture of cellulose ethers and acetate, as a flavouring agent, and as a perfume for soap etc. Therefore it is commonly available to factory workers and can be used as a means for committing suicide. 
Concentration

Diagnosis
The condition is diagnosed by the history of exposure, central cyanosis with not much depressant effect on respiration. There is persistent cyanosis on oxygen therapy without improvement in observed SaO 2 . There is also a difference between observed (pulse oximetry) and calculated (ABG) oxygen saturation. 
Treatment
It revolves mainly around gastric lavage. Stopping further exposure to the body through the skin, respiratory tract etc. O 2 therapy, and artificial ventilation if needed. Methylene blue is the antidote of choice for acquired (toxic) methaemoglobinemia. 5 It acts as an exogenous co-factor which greatly accelerates the NADPH dependent methaemoglobin reductase system. 5 Methylene blue is indicated for acquired methaemoglobinemia when the level is greater than 35 to 40% and the patient has cardiorespiratory symptoms. 5, 6 The initial dose is 1 to 2 mg/kg or 0.1 to 0.2ml/kg of the 3% solution given intravenously over five minutes. 7 Response should occur within 1hour, repeated levels of methaemoglobin can be done to asses the progress. Though in higher doses it behaves as an oxidising agent and can cause asymptomatic methaemoglobinemia 8 ascorbic acid is often mentioned as an alternative therapy, but its reducing effect is probably too slow to have significant benefit. 8 Exchange transfusions equal to or less than the total volume and up to greater than twice the volume have been used. 7 Dextrose should be given 9 because the major source of NADH in the red blood cells is the catabolism of sugar through glycolysis. Dextrose is also necessary to form NADPH through the hexose monophosphate shunt, which is necessary for methylene blue to be effective. In patients with G6PD (Glucose-6-phosphate dehydrogenase) deficiency methylene blue therapy may be ineffective because they may not be able to produce sufficient NADPH to reduce methaemoglobin to leukomethylene blue.
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Conclusion
Nitrobenzene poisoning is a fatal condition but it can be treated if IV methylene blue is available on time, exposure to the compound is limited, and life support is available to the patient. Many cases have been reported previously.
